Career Employer

FREE USMLE Step 3 Study Guide 2026: FIP, ACM & CCS

The final USMLE step, taught the way it is tested — a two-day exam built around patient management and clinical decision-making. This interactive study guide walks through Day 1 (FIP), Day 2 (ACM), the CCS case simulations, and the biostatistics that decide your three-digit score.

Check sections to boost your score

Don't know where to start?

To find us again, just search “Career Employer USMLE Step 3

By

This free USMLE Step 3 study guide teaches the final licensing exam the way it is actually tested — as a two-day assessment of whether the candidate can manage real patients in unsupervised practice.[1]

It is interactive, not a wall of text: each part of the exam has worked clinical reasoning, comparison tables, labeled diagrams, and built-in flashcards — taught to the level a practicing physician needs to clear this final milestone.

Work through it part by part, then round out your prep with our practice questions and flashcards. Step 3 has about 412 questions across two days plus the case simulations, and — unlike Step 1 — it is still reported as a three-digit numeric score (minimum 200 to pass).[4]

USMLE Step 3 Exam Snapshot

USMLE Step 3 at a glance (2026)
DetailUSMLE Step 3
Questions~412 multiple-choice questions + ~13 case simulations (CCS)
FormatTwo-day computer-based exam at a Prometric center
Day 1 (FIP)232 MCQ in 12 blocks of 30 min; ~7-hour session
Day 2 (ACM)~180 MCQ in 9 blocks + ~13 CCS; ~9-hour session
ScoringThree-digit numeric score — STILL SCORED (minimum 200 since Jan 1, 2024)
Application fee~$955 via FSMB (dated anchor — verify on fsmb.org)
EligibilityPassed Step 1 + Step 2 CK; MD/DO degree (IMGs: ECFMG certified)
Issued byUSMLE program — a joint program of the FSMB and NBME

Step 3 is the management exam. Where Step 1 is mostly applied basic science and Step 2 CK is diagnosis, Step 3 shifts decisively to patient management and clinical decision-making for unsupervised practice.[2] Two features define it: the unique , and the fact that it is still scored with a three-digit number — not Pass/Fail.

How USMLE Step 3 Is Built

Step 3 is a two-day exam built from a content blueprint that classifies every item by a physician task (diagnosis, management, communication, or interpreting the literature) and a clinical content area (organ system or topic).[2] The two days have distinct personalities, and you schedule each separately.

This guide teaches by the exam’s real structure — Day 1 (FIP), Day 2 (ACM), the CCS format, and a final high-yield clinical review — because that maps directly onto how the test is delivered and scored. The single most important mental shift from the earlier Steps is from knowledge to management: Step 3 rewards what you do for the patient.

Step 3 is reported on a . The minimum passing score is 200, effective for examinees testing on or after January 1, 2024 (raised from 198).[4] The standard is criterion-referenced, so no fixed percentage of examinees is set to pass — examinees generally need to answer about 60% of items correctly.[5]

Day 1 (FIP): Foundations, Biostatistics & the Literature

Day 1 — — has 232 multiple-choice questions and leans on applied foundational science, nutrition, and the quantitative skills a physician uses every day: biostatistics, epidemiology, and reading the medical literature.[2] This is the most reliably scorable part of Step 3 — the math does not change.

Applied Foundational Science & Nutrition

Day 1 revisits basic science, but always appliedto a clinical scenario — the mechanism behind a drug’s adverse effect, the pathophysiology that explains a lab, the pharmacokinetics that set a dose.

Nutrition is the single largest content area on Step 3, so master it: identify deficiency syndromes (thiamine in alcohol use, B12 with neurologic signs, vitamin D and calcium), and recognize — the dangerous electrolyte shift when a severely malnourished patient is fed too fast. Start feeds low (about 10–20 kcal/kg/day) and advance slowly while replacing phosphate, potassium, and magnesium.

Biostatistics, Epidemiology & Study Design

Biostatistics is a Step 3 hallmark and reliable points. Know the test-performance quartet cold: (a negative on a sensitive test rules OUT, “SnNout”), (a positive on a specific test rules IN, “SpPin”), and the predictive values, where rises with prevalence.

For treatment effect, compute the as the reciprocal of the absolute risk reduction. For study design, cohort studies yield , case-control studies yield the odds ratio, and the randomized controlled trial is the gold standard for causation.

Diagnostic test performance (high-yield biostatistics)
MeasureDefinition (in words)Use
SensitivityTrue positives among the diseasedHigh → good screening test (SnNout)
SpecificityTrue negatives among the healthyHigh → good confirmatory test (SpPin)
Positive predictive valueDiseased among the test-positiveRises with prevalence
Negative predictive valueHealthy among the test-negativeFalls with prevalence
Number needed to treatReciprocal of absolute risk reductionLower = more effective treatment

Checkpoint · Day 1 (FIP): Foundations, Biostatistics & the Literature

Question 1 of 10

A test has a sensitivity of 90%. What is the corresponding false-negative rate?

Day 1 (FIP): Ethics, Communication & Patient Safety

The social-science items — ethics, communication, and patient safety — are heavily tested on Day 1 and reward the patient-centered, principled choice rather than a memorized fact.[2] They are pure points if you reason from the four principles (autonomy, beneficence, non-maleficence, justice).

Medical Ethics & Informed Consent

requires decision-making capacity, adequate disclosure (diagnosis, intervention, risks, benefits, and alternatives — including no treatment), understanding, and voluntariness, with narrow exceptions (emergencies, waiver, therapeutic privilege).[10] Distinguish (a clinical, decision-specific judgment the physician makes) from competency (a global legal determination by a court): a patient with capacity may refuse even life-saving treatment.

When a patient lacks capacity, follow an advance directive or a surrogate using substituted judgment. Know the minor-consent exceptions (emergencies, sexually transmitted infections, contraception, pregnancy, substance use, emancipation), and the duties to maintain confidentiality and to disclose medical errors honestly.

Patient Safety & Quality Improvement

Patient-safety items test systems thinking. Recognize the Swiss-cheese model (errors line up through layered defenses), distinguish active errors (at the sharp end) from latent system failures, and prefer system fixes (forcing functions, checklists, computerized order entry with decision support) over blaming individuals.

Use root-cause analysis to look back at an event and failure-mode-and-effects analysis to look forward at a process. Know error types — a near miss reaches no patient, an adverse event causes harm, and a sentinel event is a serious, reportable harm — and the just-culture principle of separating human error from reckless behavior.

The four principles of medical ethics
PrincipleMeaningTypical Step 3 application
AutonomyRespect the patient's right to decideA patient with capacity may refuse treatment
BeneficenceAct in the patient's best interestRecommend the intervention most likely to help
Non-maleficenceDo no harmAvoid unnecessary, risky, or futile interventions
JusticeTreat patients fairly; allocate resources equitablyNo discrimination in access or care

Checkpoint · Day 1 (FIP): Ethics, Communication & Patient Safety

Question 1 of 10

Which statement most accurately distinguishes informed consent from a signed consent form?

Day 2 (ACM): Diagnosis & the Patient-Care Framework

Day 2 — — moves from foundations to the bedside. Step 3 organizes clinical encounters by the , so before you can manage, you must place the patient in the right frame and reach the right diagnosis.[2]

Initial, Continued & Urgent Care

Every Step 3 vignette sits in one of three care stages, and the stage tells you what to do. In initial care, an undifferentiated patient presents — your job is to build a differential and order the initial, highest-yield diagnostics. In continued care, you manage a known condition over time — monitoring, adjusting therapy, providing and screening, and discussing prognosis.

In urgent intervention, the patient is unstable — you stabilize first (airway, breathing, circulation) and treat the immediate threat before completing the workup. Reading which stage you are in is half the battle: the same diagnosis demands different actions at first presentation, in chronic follow-up, and in crisis.

Building a Differential & Choosing Tests

On Step 3, the diagnostic test you order should change management. Start with the most likely diagnoses and the can’t-miss ones, then choose the test that confirms or excludes them most efficiently — and weigh , , and pre-test probability.

A highly sensitive test is best to screen and rule out; a highly specific test is best to confirm. Avoid the trap of ordering a test that will not alter what you do. When a vignette describes a classic presentation, the best next step is often to treat empirically rather than to order another confirmatory test.

What the care stage tells you to do
Care stagePatientYour priority
Initial careUndifferentiated, first presentationBuild a differential; order initial diagnostics
Continued careKnown condition, follow-upMonitor, adjust therapy, health maintenance, prognosis
Urgent interventionUnstable / time-criticalStabilize (ABCs); treat the immediate threat first

Checkpoint · Day 2 (ACM): Diagnosis & the Patient-Care Framework

Question 1 of 10

A 73-year-old man is being discharged after an admission for acute decompensated heart failure. Which intervention most reduces his risk of early readmission?

Day 2 (ACM): Management & Therapeutics

Management is the heart of Step 3 — the competency that grows the most from the earlier Steps. Day 2 rewards choosing the right therapy, monitoring it, and adjusting it over time, guided by the patient’s comorbidities.[2]

Chronic Disease Management & Health Maintenance

Chronic-disease items reward matching the drug to the comorbidity and following the patient over time. In hypertension, first-line agents are thiazides, ACE inhibitors or ARBs, and calcium channel blockers — pick the ACE inhibitor or ARB in diabetes with albuminuria.

In diabetes, metformin is first-line, with SGLT2 inhibitors or GLP-1 agonists added for cardiovascular or renal benefit. In atrial fibrillation, choose rate control for most patients and base anticoagulation on the .

Layer in : age- and risk-appropriate cancer screening (for example, colorectal screening beginning at age 45) and immunizations on the current CDC schedule. The recurring Step 3 skill is the longitudinal view — treat to target, monitor, and prevent the next complication.

Therapeutics & Monitoring

Know not just which drug but how to monitor it: warfarin by the INR, heparin by the aPTT (or anti-Xa), aminoglycosides and vancomycin by levels and renal function, statins for myopathy, and amiodarone for thyroid, lung, and liver toxicity. Recognize the high-yield drug interactions and the contraindications (ACE inhibitors in pregnancy, metformin around iodinated contrast and in renal impairment, beta-blockers in decompensated heart failure). When a patient develops a new problem, ask first whether a medication caused it — an adverse drug effect is a constant Step 3 answer.

High-yield chronic-disease first-line management
ConditionFirst-line / key choiceThe Step 3 nuance
HypertensionThiazide, ACE inhibitor/ARB, or CCBACE inhibitor/ARB in diabetes with albuminuria
Type 2 diabetesMetformin first-lineAdd SGLT2 inhibitor / GLP-1 agonist for CV or renal benefit
Atrial fibrillationRate control for most; anticoagulate by CHA2DS2-VAScUnstable → immediate synchronized cardioversion
Heart failure (reduced EF)ACE inhibitor/ARB/ARNI + beta-blocker + diureticAdd SGLT2 inhibitor and an aldosterone antagonist
Asthma / COPDInhaled controller therapyCOPD exacerbation: bronchodilators, steroids, target SpO2 88–92%

Checkpoint · Day 2 (ACM): Management & Therapeutics

Question 1 of 10

A 47-year-old woman is found to have a 1.5 cm solitary thyroid nodule on examination. Her TSH is normal. What is the most appropriate next step in evaluation?

Computer-Based Case Simulations (CCS)

The is the format that makes Step 3 unique. On Day 2 you manage about 13 simulated patients over advancing clock time — there are no answer choices, only the orders you enter and the consequences that follow.[3]

How CCS Works

Each case opens with a patient in a setting (office, emergency department, or ward). You type orders — history elements, physical-exam components, labs, imaging, medications, consults, and monitoring — and results return after simulated time passes. You can advance the simulated clockor move the patient to a different location (for example, from the office to the ED to the ICU), and the patient’s condition evolves with your management.

Each case is allotted up to 10 or 20 minutes of real time; the case ends on its own clock. There is no single “right answer” — the software scores whether your management was appropriate, timely, and safe.

CCS Strategy & Common Pitfalls

Treat the CCS like real practice with two habits layered on. First, act on urgency: for an unstable patient, order the time-critical interventions (oxygen, IV access, monitoring, the immediate treatment) before advancing the clock — and place the patient in the right location.

Second, do not over-order: every unnecessary, invasive, or risky order can cost you, just as in real care; order what changes management, then move time forward to reassess. Remember frequent re-evaluation, confirmatory tests when appropriate, and routine items like counseling and prophylaxis.

The biggest avoidable mistakes are advancing the clock on an unstable patient before treating, ordering harmful or excessive tests, and forgetting to reassess after an intervention. Practice the mechanics with the free so the interface never slows you down.

CCS — do this, avoid that
DoAvoid
Treat urgent threats before advancing the clockAdvancing time on an unstable patient before treating
Order what changes management, then reassessOver-ordering invasive or risky tests
Move the patient to the correct setting (ED, ICU)Leaving an unstable patient in the office
Re-evaluate after every interventionForgetting to reassess once orders are placed
Add routine prophylaxis, counseling, monitoringIgnoring health maintenance and supportive care

Checkpoint · Computer-Based Case Simulations (CCS)

Question 1 of 10

A 28-year-old woman with iron deficiency anemia is prescribed oral iron but reports poor absorption. Which counseling point best optimizes oral iron absorption?

High-Yield Clinical Content by System

Both days draw on every clinical content area. This module collects the highest-yield, most-tested management points — with special attention to the unstable patient, where timing decides the outcome.[2]

The Unstable Patient & Acute Management

Acute, multisystem emergencies are where Step 3 and the CCS overlap most. In , obtain blood cultures and a lactate, give broad-spectrum antibiotics within the first hour, and resuscitate with IV crystalloid; add norepinephrine if hypotension persists after fluids.[11]

In , give IV fluids, an insulin infusion, and potassium — but check the potassium before insulin, because insulin drives it into cells and can cause fatal hypokalemia. For acute coronary syndrome, give aspirin and obtain an ECG immediately, then reperfuse a STEMI.

For anaphylaxis, give intramuscular epinephrine first. The unifying principle: recognize instability, stabilize the airway, breathing, and circulation, and deliver the time-critical treatment before completing the workup.

Organ-System High-Yield Topics

Round out your review with the most-tested topics by system:

  • in cardiology, heart-failure therapy and the management of atrial fibrillation;
  • in pulmonology, COPD and asthma management and the workup of a pulmonary embolism;
  • in gastroenterology, GI bleeding and liver disease;
  • in endocrinology, thyroid disorders and diabetes complications;
  • in nephrology, acute kidney injury and electrolyte disturbances;
  • in obstetrics, prenatal care and the hypertensive disorders of pregnancy;
  • in neurology, stroke and seizure management;
  • in psychiatry, depression, the use of antidepressants, and suicide-risk assessment; and
  • in dermatology, the recognition of skin cancers and serious drug eruptions.

For each, focus on the management step Step 3 rewards, not just the diagnosis.

Acute emergencies — the first, time-critical action
EmergencyFirst actionKey caution
SepsisCultures + lactate, antibiotics within 1 hour, IV fluidsAdd norepinephrine if hypotensive after fluids
Diabetic ketoacidosisIV fluids, insulin infusion, potassiumCheck potassium BEFORE starting insulin
STEMIAspirin + ECG, then reperfusion (PCI)Do not delay reperfusion
AnaphylaxisIntramuscular epinephrineEpinephrine first — before antihistamines/steroids
Unstable tachyarrhythmiaSynchronized cardioversionStabilize before elective workup

Checkpoint · High-Yield Clinical Content by System

Question 1 of 10

A 35-year-old woman is noted to have unilateral ptosis, miosis, and decreased sweating of the face on the same side. Which of the following best describes this constellation of findings?

How to Use This Study Guide

Work through the guide part by part. After each one, check it off in the contents to raise your exam-readiness score, then drill the same content in our free practice questions and flashcards — active recall and timed practice are what move knowledge into exam-day performance.

  • Lead with biostatistics and management. Biostatistics is reliable, repeatable points; management is the bulk of Day 2 — both reward practice over memorization.
  • Practice the CCS early. Download the free Primum software and run cases until the interface is second nature — don’t learn the mechanics on exam day.
  • Read the care stage. Decide whether you are in initial, continued, or urgent care — it dictates whether to work up, maintain, or stabilize.
  • Think in “best next step.” Step 3 rewards what you DO — the highest-yield action right now, not just the diagnosis.
  • Aim for a comfortable margin. Step 3 is still scored, so target a confident score above 200, not a bare pass.
  • Then prove it. When a part feels solid, confirm with our timed practice questions before exam day.

Common concepts USMLE Step 3 candidates study and get asked — each answered briefly and backed by an official source (USMLE, NIH/NCBI, CDC, or the USPSTF). Tap any card to test yourself.

USMLE Step 3 Concept Questions

USMLE Step 3 Glossary

Key USMLE Step 3 terms in one place. Hover any dotted term throughout the guide for its definition; the full list is below.

USMLE Step 3
The third and final examination in the United States Medical Licensing Examination sequence — a two-day, computer-based test of about 412 multiple-choice questions plus roughly 13 computer-based case simulations. It assesses whether a physician can apply medical knowledge and clinical science to the unsupervised practice of medicine, and it is reported as a three-digit numeric score (minimum 200 to pass).
FIP
Foundations of Independent Practice — Day 1 of Step 3. It has 232 multiple-choice questions in 12 blocks and emphasizes applied foundational science, biostatistics and epidemiology, interpretation of the medical literature, social sciences, and communication.
ACM
Advanced Clinical Medicine — Day 2 of Step 3. It has about 180 multiple-choice questions in 9 blocks plus about 13 computer-based case simulations, and emphasizes diagnosis, prognosis, management, and clinical decision-making for evolving patients.
CCS
Computer-based Case Simulation — an interactive patient-management format unique to Step 3 (Day 2). You manage a simulated patient over advancing clock time, ordering history, exams, tests, and treatments and watching the condition change. There is no single right answer; appropriate, timely management is scored.
three-digit score
The numeric scoring scale on which Step 3 (and Step 2 CK) results are reported. Step 3's minimum passing score is 200, effective for examinees testing on or after January 1, 2024 (raised from 198). Step 1, by contrast, is reported Pass/Fail only.
patient-care framework
The way Step 3 organizes clinical encounters by the stage of care — initial care (first presentation and workup), continued care (chronic management, monitoring, and health maintenance), and urgent intervention (acute, time-critical management).
decision-making capacity
A clinical, decision-specific judgment that a patient can understand the relevant information, appreciate how it applies to them, reason about the options, and communicate a consistent choice. It is distinct from competency, which is a global legal determination made by a court.
informed consent
The process by which a patient with capacity, after adequate disclosure of the diagnosis, intervention, risks, benefits, and alternatives, voluntarily agrees to care. Exceptions are narrow — emergencies, waiver, and therapeutic privilege.
sensitivity
The proportion of people with a disease who test positive (the true-positive rate); a highly sensitive test, when negative, helps rule a disease OUT (SnNout). It is independent of disease prevalence.
specificity
The proportion of people without a disease who test negative (the true-negative rate); a highly specific test, when positive, helps rule a disease IN (SpPin). It is independent of disease prevalence.
positive predictive value
The probability that a person with a positive test truly has the disease. Unlike sensitivity and specificity, it depends on prevalence — rising as prevalence rises and falling as prevalence falls.
number needed to treat
The number of patients who must receive a treatment for one additional patient to benefit; it equals the reciprocal of the absolute risk reduction. A lower number needed to treat means a more effective treatment.
relative risk
The risk of an outcome in an exposed group divided by the risk in an unexposed group, derived from a cohort study; the odds ratio (from case-control studies) approximates it for rare outcomes.
refeeding syndrome
A dangerous fluid and electrolyte shift when nutrition is reintroduced to a severely malnourished patient; insulin drives phosphate, potassium, and magnesium into cells. Prevent it by starting low-calorie feeds and advancing slowly with electrolyte monitoring.
CHA2DS2-VASc score
A clinical score that estimates stroke risk in atrial fibrillation from congestive heart failure, hypertension, age, diabetes, prior stroke or TIA, vascular disease, and sex, and guides the decision to anticoagulate.
health maintenance
Preventive care delivered at routine visits — age- and risk-appropriate screening, immunizations, and counseling — a core Step 3 management task, especially in the ambulatory setting.
sepsis
Life-threatening organ dysfunction caused by a dysregulated host response to infection; early management bundles cultures and lactate, broad-spectrum antibiotics within the first hour, and crystalloid resuscitation, with vasopressors if hypotension persists.
diabetic ketoacidosis
An acute, life-threatening complication of diabetes with hyperglycemia, ketosis, and an anion-gap metabolic acidosis; managed with IV fluids, an insulin infusion, and potassium repletion (check potassium before starting insulin).
Primum CCS software
The free practice software provided by the USMLE program that mimics the computer-based case simulation interface, so candidates can learn the order-entry and clock-advancing mechanics before exam day.

USMLE Step 3 Study Guide FAQ

USMLE Step 3 is still SCORED — it is reported as a three-digit numeric score, not pass/fail. This is a key contrast with Step 1, which became Pass/Fail only on January 26, 2022. Step 3's minimum passing score is 200, effective for examinees testing on or after January 1, 2024 (raised from 198). The single score combines the Day 1 and Day 2 multiple-choice items and the case simulations.

References

  1. 1.USMLE Program (FSMB and NBME). “Step 3 Overview.” usmle.org.
  2. 2.USMLE Program (FSMB and NBME). “Step 3 Exam Content.” usmle.org.
  3. 3.USMLE Program (FSMB and NBME). “Computer-based Case Simulations.” usmle.org.
  4. 4.USMLE Program (FSMB and NBME). “Change to Step 3 Passing Standard Begins January 1, 2024.” usmle.org.
  5. 5.USMLE Program (FSMB and NBME). “Bulletin of Information: Scoring and Score Reporting.” usmle.org.
  6. 6.USMLE Program (FSMB and NBME). “Bulletin of Information: Eligibility.” usmle.org.
  7. 7.Federation of State Medical Boards (FSMB). “USMLE Step 3 Application Fees.” fsmb.org.
  8. 8.USMLE Program (FSMB and NBME). “Performance Data.” usmle.org.
  9. 9.National Institutes of Health (NIH). “Sensitivity and Specificity.” ncbi.nlm.nih.gov.
  10. 10.National Institutes of Health (NIH). “Informed Consent.” ncbi.nlm.nih.gov.
  11. 11.National Institutes of Health (NIH). “Sepsis.” ncbi.nlm.nih.gov.
  12. 12.U.S. Preventive Services Task Force (USPSTF). “Colorectal Cancer: Screening.” uspreventiveservicestaskforce.org.
  13. 101.National Institutes of Health (NIH). “Sensitivity, Specificity, and Predictive Values.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  14. 102.National Institutes of Health (NIH). “Number Needed to Treat.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  15. 103.National Institutes of Health (NIH). “Decision-Making Capacity.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  16. 104.National Institutes of Health (NIH). “Acute Coronary Syndrome.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  17. 105.National Institutes of Health (NIH). “Refeeding Syndrome.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  18. 106.Centers for Disease Control and Prevention (CDC). “Immunization Schedules.” cdc.gov, accessed 19 June 2026.
  19. 107.National Institutes of Health (NIH). “Atrial Fibrillation.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  20. 108.National Institutes of Health (NIH). “Hypertension.” ncbi.nlm.nih.gov, accessed 19 June 2026.
  21. 109.National Institutes of Health (NIH). “Chronic Obstructive Pulmonary Disease (COPD).” ncbi.nlm.nih.gov, accessed 19 June 2026.
  22. 110.National Institutes of Health (NIH). “Diabetic Ketoacidosis.” ncbi.nlm.nih.gov, accessed 19 June 2026.
Career Employer

Career Employer is the ultimate resource to help you get started working the job of your dreams. We cover topics from general career information, career searching, exam preparation with free study materials, career interviewing, and becoming successful in your career of choice.

Follow Us:

All Posts

Career Employer’s Editorial Process

Here at Career Employer, we focus a lot on providing factually accurate information that is always up to date. We strive to provide correct information using strict editorial processes, article editing, and fact-checking for all of the information found on our website. We only utilize trustworthy and relevant resources. To find out more, make sure to read our full editorial process page here.